Track infections in newborns to improve care
Part of Infections clinical trials.
This study collects information about newborns in participating hospital units who have an infection confirmed by a lab test. The goal is to better understand infection patterns so care for newborns can improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is a newborn in a participating neonatal (newborn) unit
- Your baby has had an infection episode with a positive lab culture test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the antibiotic vancomycin moves through and acts in newborn babies. It may help doctors dose the medicine more safely and effectively for babies in intensive care.
This study checks how a newborn’s body changes over time in an intensive care unit, using routine monitoring. Your child may benefit by being closely observed, and the results may help improve care for future newborns.
This study looks at germs that cause infections in newborns and which antibiotics work best against them. It aims to help doctors choose the right treatment for babies in the intensive care unit.
This study is testing a new blood test to see if it can help doctors decide when to use antibiotics for newborns who may have a late-onset infection. The goal is to reduce unnecessary antibiotic use.
This study is testing if giving more skin-to-skin care (called Kangaroo Care) to very early-born babies in the NICU can reduce serious infections and the spread of resistant bacteria. It is for babies born before 32 weeks in certain hospitals.
This study looks at two substances in the blood from the umbilical cord (IL-6 and lactate) to see if they can help doctors understand how well a newborn is doing after birth.
Hear when a new Neonatal Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.